COVID-19 vaccine effectiveness and variants in Nepal: study protocol for a test-negative case–control study with SARS-CoV-2 genetic sequencing

التفاصيل البيبلوغرافية
العنوان: COVID-19 vaccine effectiveness and variants in Nepal: study protocol for a test-negative case–control study with SARS-CoV-2 genetic sequencing
المؤلفون: Bijukchhe, SM, O'Reilly, PJ, Theiss-Nyland, K, Gurung, M, Pokhrel, B, Kelly, S, Acharya, S, Maharjan, S, Shrestha, A, Pandey, B, Lama, M, Shrestha, I, Voysey, M, Eordogh, A, Shrestha, S, Feng, ES, Li, G, Shah, G, Pollard, AJ
المصدر: BMJ Open. 13:e068334
بيانات النشر: BMJ, 2023.
سنة النشر: 2023
مصطلحات موضوعية: General Medicine
الوصف: IntroductionInactivated, viral vector and mRNA vaccines have been used in the Nepali COVID-19 vaccination programme but there is little evidence on the effectiveness of these vaccines in this setting. The aim of this study is to describe COVID-19 vaccine effectiveness in Nepal and provide information on infections with SARS-CoV-2 variants.Methods and analysisThis is a hospital-based, prospective test-negative case–control study conducted at Patan Hospital, Kathmandu. All patients >18 years of age presenting to Patan Hospital with COVID-19-like symptoms who have received a COVID-19 antigen/PCR test are eligible for inclusion. The primary outcome is vaccine effectiveness of licensed COVID-19 vaccines against laboratory-confirmed COVID-19 disease.After enrolment, information will be collected on vaccine status, date of vaccination, type of vaccine, demographics and other medical comorbidities. The primary outcome of interest is laboratory-confirmed SARS-CoV-2 infection. Cases (positive for SARS-CoV-2) and controls (negative for SARS-CoV-2) will be enrolled in a 1:4 ratio. Vaccine effectiveness against COVID-19 disease will be analysed by comparing vaccination status with SARS-CoV-2 test results.Positive SARS-CoV-2 samples will be sequenced to identify circulating variants and estimate vaccine effectiveness against common variants.Measuring vaccine effectiveness and identifying SARS-CoV-2 variants in Nepal will help to inform public health efforts. Describing disease severity in relation to specific SARS-CoV-2 variants and vaccine status will also inform future prevention and care efforts.Ethics and disseminationEthical approval was obtained from the University of Oxford Tropical Ethics Committee (OxTREC) (ref: 561-21) and the Patan Academy of Health Sciences Institutional Review Board (ref: drs2111121578). The protocol and supporting study documents were approved for use by the Nepal Health Research Council (NHRC 550-2021). Results will be disseminated in peer-reviewed journals and to the public health authorities in Nepal.
تدمد: 2044-6055
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0d2e0bdf5dabd8a4120e092d664b24eTest
https://doi.org/10.1136/bmjopen-2022-068334Test
حقوق: OPEN
رقم الانضمام: edsair.doi.dedup.....f0d2e0bdf5dabd8a4120e092d664b24e
قاعدة البيانات: OpenAIRE